# Comparing RadiaPlexRx Hydrogel and Standard-of-Care for Radiation Dermatitis in Breast Cancer Patients

> **NCT00481884** · PHASE3 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 80 (actual)

## Conditions studied

- Radiation Dermatitis

## Interventions

- **OTHER:** RadiaPlexRx Gel
- **OTHER:** Aquaphor Gel

## Key facts

- **NCT ID:** NCT00481884
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2016-05-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00481884

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00481884, "Comparing RadiaPlexRx Hydrogel and Standard-of-Care for Radiation Dermatitis in Breast Cancer Patients". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00481884. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*